DOCSLIB.ORG

An Investigation of Late Onset Psoriasis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
An Investigation of Late Onset Psoriasis AN INVESTIGATION OF LATE ONSET PSORIASIS A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy (PhD) in the Faculty of Medical and Human Sciences 2013 ELENI THEODORAKOPOULOU SCHOOL OF MEDICINE 1 Table of Contents List of figures __________________________________________________________________ 7 List of tables ___________________________________________________________________ 8 Abstract ______________________________________________________________________ 14 Declaration ___________________________________________________________________ 15 Copyright statement ___________________________________________________________ 15 Acknowledgements ____________________________________________________________ 16 Dedication ____________________________________________________________________ 16 Published abstracts arising from this thesis _______________________________________ 17 1. Introduction ______________________________________________________________ 18 1.1 Historical background of psoriasis ________________________________________ 18 1.2 Epidemiology of psoriasis _______________________________________________ 18 1.3 Clinical phenotypes of psoriasis _________________________________________ 19 1.3.1 Plaque psoriasis ___________________________________________________ 19 1.3.2 Guttate psoriasis ___________________________________________________ 23 1.3.3 Pustular psoriasis __________________________________________________ 24 1.3.3.1 Generalised pustular psoriasis____________________________________ 24 1.3.3.2 Localised pustular psoriasis ______________________________________ 25 1.3.4 Erythrodermic psoriasis _____________________________________________ 26 1.3.5 Eczematous psoriasis _______________________________________________ 26 1.3.6 Photosensitive psoriasis _____________________________________________ 27 1.4 Histology of normal skin ________________________________________________ 27 1.4.1 Histology of psoriasis _______________________________________________ 28 1.4.2 Inflammatory changes of psoriasis _____________________________________ 31 1.5 Pathogenesis of psoriasis _______________________________________________ 32 1.5.1 Genetics of psoriasis ________________________________________________ 32 1.5.2 The role of cellular and humoral immune response in psoriasis _______________ 35 1.5.3 Environmental and psychological influences in psoriasis ____________________ 40 1.6 Psoriasis associated comorbidities _______________________________________ 41 1.7 Management of psoriasis________________________________________________ 42 1.8 Other phenotypic classifications of psoriasis _______________________________ 43 1.9 Early and late onset psoriasis ____________________________________________ 45 1.9.1 Defining the age of onset ____________________________________________ 45 1.9.2 Clinical differences between early and late onset psoriasis __________________ 45 1.9.3 Genetic differences between early and late onset psoriasis _________________ 47 2 1.9.4 Immunological differences ___________________________________________ 48 1.9.5 Identifying the knowledge gap ________________________________________ 49 1.10 Summary _____________________________________________________________ 50 1.11 Hypothesis, aims and objectives _________________________________________ 52 1.12 Study design __________________________________________________________ 53 2. Materials and methods _____________________________________________________ 54 2.1 Clinical and psychological evaluation of early and late onset psoriasis _________ 54 2.1.1 Study design ______________________________________________________ 54 2.1.2 Prospective cohort _________________________________________________ 54 2.1.2.1 Study population ________________________________________________ 54 2.1.2.2 Ethical approval and study specific training ___________________________ 55 2.1.2.3 Inclusion and exclusion criteria ____________________________________ 55 2.1.2.4 Study questionnaire ______________________________________________ 55 2.1.2.4.1 The clinical section of the questionnaire __________________________ 56 2.1.2.4.2 Demographic characteristics ___________________________________ 56 2.1.2.4.3 Social history _______________________________________________ 56 2.1.2.4.4 Medical history ______________________________________________ 56 2.1.2.4.5 Drug history ________________________________________________ 57 2.1.2.4.6 Family history _______________________________________________ 57 2.1.2.4.7 Triggering factors ____________________________________________ 57 2.1.2.4.8 Clinical phenotype and disease severity __________________________ 57 2.1.2.4.9 Psoriasis Area and Severity Index_______________________________ 58 2.1.2.4.10 Patient Global Psoriasis Assessment ____________________________ 60 2.1.2.4.11 Assessing nail changes _______________________________________ 61 2.1.2.5 The psychometric sections of the questionnaire ________________________ 61 2.1.2.5.1 Dermatology Life Quality Index _________________________________ 61 2.1.2.5.2 Hospital Anxiety and Depression Scale __________________________ 62 2.1.2.5.3 Beck Depression Inventory-II __________________________________ 63 2.1.2.5.4 Penn State Worry Questionnaire ________________________________ 64 2.1.3 The retrospective group _____________________________________________ 65 2.1.4 The control group __________________________________________________ 66 2.1.4.1 iSOFT and Salford Integrated Records ______________________________ 66 2.1.5 Statistical analysis _________________________________________________ 67 2.2 Histological and immunohistochemical evaluation of early and late onset psoriasis ___________________________________________________________________________ 68 2.2.1 Study design ______________________________________________________ 68 2.2.2 Study population ___________________________________________________ 68 2.2.2.1 Ethical approval and study specific training ___________________________ 68 2.2.2.2 Study visits ____________________________________________________ 68 2.2.2.3 Screening visit __________________________________________________ 69 3 2.2.2.4 Main study visit _________________________________________________ 69 2.2.2.5 Inclusion and exclusion criteria _____________________________________ 69 2.2.3 Punch biopsy protocol ______________________________________________ 70 2.2.4 Histological assessment ____________________________________________ 71 2.2.4.1 Haematoxylin and eosin and periodic-acid-Schiff protocol ________________ 71 2.2.4.1.1 Haematoxylin & Eosin ________________________________________ 72 2.2.4.1.2 Periodic acid Schiff __________________________________________ 72 2.2.5 Psoriasis Histological Assessment Score ________________________________ 72 2.2.6 Immunohistochemical assessment ____________________________________ 77 2.2.6.1 Immunohistochemical staining _____________________________________ 77 2.2.7 Statistical analysis _________________________________________________ 79 3. A clinical investigation of early and late onset psoriasis _________________________ 81 3.1 Introduction ___________________________________________________________ 81 3.2 Objectives ____________________________________________________________ 82 3.3 Methods ______________________________________________________________ 82 3.3.1 Psoriasis prospective arm of the questionnaire ___________________________ 82 3.3.2 Psoriasis retrospective arm of the questionnaire __________________________ 82 3.3.3 Control group _____________________________________________________ 83 3.3.4 Study cohort and clinical evaluation ____________________________________ 83 3.3.5 Assessing disease severity ___________________________________________ 84 3.3.6 Assessing the clinical phenotype ______________________________________ 84 3.3.7 Assessing family history of psoriasis ___________________________________ 84 3.3.8 Assessing psoriasis-related comorbidities _______________________________ 85 3.3.9 Assessing triggering factors of psoriasis ________________________________ 85 3.3.10 Assessing psychological impairment ___________________________________ 85 3.3.11 Measurement of other covariates ______________________________________ 85 3.3.12 Sample size and study power _________________________________________ 86 3.3.13 Statistical analysis _________________________________________________ 86 3.4 Results _______________________________________________________________ 88 3.4.1 Demographic data of enrolled patients __________________________________ 88 3.4.1.1 General characteristics ___________________________________________ 88 3.4.1.2 Familial predisposition to psoriasis __________________________________ 89 3.4.2 Social characteristics _______________________________________________ 92 3.4.3 Clinical characteristics ______________________________________________ 93 3.4.3.1 Disease severity ________________________________________________ 93 3.4.3.2 Clinical Phenotype ______________________________________________ 94 3.4.3.3 Therapeutic management _________________________________________ 97 3.4.4 Associated comorbidities ____________________________________________ 99 3.4.4.1 Psoriatic Arthritis ________________________________________________ 99 3.4.4.2 Type II Diabetes Mellitus _________________________________________ 100 4 3.4.4.3 Autoimmune Diseases __________________________________________ 101 3.4.4.4 Other comorbidities _____________________________________________ 101 3.4.5 Psychological impact
Load more

Recommended publications
  • Pdf/Bus Etat Des Lieux.Pdf Dermato-Allergol Bruxelles
    1. w Volume 11, Number 2 April 2020 ISSN: 2081-9390 p. 113 - 223 DOI: 10.7241/ourd Issue online since Thursday April 02, 2020 Our Dermatology Online www.odermatol.com - Soraya Aouali, Imane Alouani, Hanane Ragragui, Nada Zizi, Siham Dikhaye A case of epithelioid angiosarcoma in a young man with chronic lymphedema - Iyda El Faqyr, Maria Dref, Sara Zahid, Jamila Oualla, Nabil Mansouri, Hanane Rais, Ouafa Hocar, Said Amal Syringocystadenoma papilliferum presented as an ulcerated nodule of the vulva in a patient with Neurofibromatosis type 1 - FMonisha Devi Selvakumari, Bittanakurike Narasappa Raghavendra, Anjan Kumar Patra A case of infantile Sweet’s syndrome - Anissa Zaouak, Leila Bouhajja, Houda Hammami, Samy Fenniche Penile annular lichen planus 2 / 2020 e-ISSN: 2081-9390 Editorial Pages DOI: 10.7241/ourd Quarterly published since 01/06/2010 years Our Dermatol Online www.odermatol.com Editor in Chief: Publisher: Piotr Brzeziński, MD Ph.D Our Dermatology Online Address: Address: ul. Braille’a 50B, 76200 Słupsk, Poland ul. Braille’a 50B, 76200 Słupsk, Poland tel. 48 692121516, fax. 48 598151829 tel. 48 692121516, fax. 48 598151829 e-mail: [email protected] e-mail: [email protected] Associate Editor: Ass. Prof. Viktoryia Kazlouskaya (USA) Indexed in: Universal Impact Factor for year 2012 is = 0.7319 system of opinion of scientific periodicals INDEX COPERNICUS (8,69) (Academic Search) EBSCO (Academic Search Premier) EBSCO MNiSW (kbn)-Ministerstwo Nauki i Szkolnictwa Wyższego (7.00) DOAJ (Directory of Open Acces Journals) Geneva Foundation
    [Show full text]
  • Genital Psoriasis: a Systematic Literature Review on This Hidden Skin Disease
    Acta Derm Venereol 2011 ; 91 ; 5-11 REVIEW ARTICLE Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease Kim A. P. MEEUWIS'-^ Joanne A. DE HULLU^ Leon F. A. G. MASSUGER^ Peter C. M. VAN DE KERKHOF' and Michelle M. VAN ROSSUM' Departments of 'Dermatology and 'Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands It is well known that the genital skin may be affected by of inverse psoriasis (synonym: flexural or intertriginous psoriasis. However, little is known about the prevalence psoriasis) (2, 4, 5). and clinical appearance of genital psoriasis, and genital The external genital skin is generally classified as skin is often neglected in the treatment of psoriatic pa- flexural skin, although it forms a unique area compri- tients. We performed an extensive systematic literature sing different structures and types of epithelium. The search for evidence-based data on genital psoriasis with epithelium covering the different structures of the vulva respect to epidemiology, aetiology, clinical and histopat- changes from stratified, keratinised squamous cell epit- hological presentation, diagnosis and treatment. Three helium on the outer parts to mucosa on the innermost bibliographical databases (PubMed, EMBASE and the regions (5, 6). Similarly, the male genital epithelium Cochrane Library) were used as data sources. Fifty-nine has a different pattern of keratinisation throughout the articles on genital psoriasis were included. The results genital area. The prepuce forms the anatomical cover- show that psoriasis frequently affects the genital skin, ing of the glans penis and is the junction between the but that evidence-based data with respect to the efficacy mucosal surface of the glans and coronal sulcus and the and safety of treatments for genital psoriasis are extre- keratinised squamous cell epithelium of the remaining mely limited.
    [Show full text]
  • Papulosquamous Disorders (Psoriasis, Lichen Planus
    PAPULOSQUAMOUS DISORDERS (PSORIASIS, LICHEN PLANUS & PITYRIASIS ROSEA) Objective of the lecture: • To know the definition of papulosquamous pattern. • To know the group of diseases known as papulosquamous diseases. • Psoriasis pathogenesis, clinical presentation, and management. • Lichen planus pathogenesis, clinical presentation, and management. • Pityriasis rosea pathogenesis, clinical presentation, and management. Done by team leader: Ghada Alhadlaq members: Rawan Alwadee & Deena AlNouwaiser. Revised by: Shrooq Alsomali Before you start.. CHECK THE EDITING FILE Sources: doctor’s slides and notes + Group B teamwork [ Color index: Important|doctor notes|Extra] Papulosquamous diseases: • The term squamous refers to scaling that represents thick Stratum Corneum and thus implies an abnormal keratinization process. - Keratinization is the differentiation of basal keratinocytes. - The basal keratinocytes as they move upward, they accumulate keratin inside them & their organelles totally die. • Papulosquamous diseases are typically characterized by scaly papules (papule = elevated lesion). • It could be papule or plaque, but the papulosquamous is the reaction pattern of the disease which means a reaction (inflammation) inside the skin (within the epidermis & dermis) to a specific thing that presents itself on the surface of the skin with a certain morphology. • Other disease patterns include psoriasiform, lichenoid, bullous, pustular as well as papulosquamous pattern & each has many differential diagnoses. :)الصدفية( Psoriasis • Chronic non-contagious polygenic multisystem inflammatory disease. • Psoriasis can be triggered by infections, trauma, stress and medications. • The characteristic lesion (classical psoriatic lesion) is a sharply demarcated erythematous scaly plaque that may be localized or generalized. • The natural history follows a chronic course with intermittent remissions. • Has two peaks in age of onset (bi-model age presentation): one at 20-30 years and a second at 40-50.
    [Show full text]
  • Differential Diagnosis and Treatment of Itching in Children and Adolescents
    biomedicines Review Differential Diagnosis and Treatment of Itching in Children and Adolescents Seok-Young Kang † , Ji-Young Um † , Bo-Young Chung , Jin-Cheol Kim , Chun-Wook Park and Hye-One Kim * Department of Dermatology, Kangnam Sacred Heart Hospital, Hallym University, Seoul KS013, Korea; [email protected] (S.-Y.K.); [email protected] (J.-Y.U.); [email protected] (B.-Y.C.); [email protected] (J.-C.K.); [email protected] (C.-W.P.) * Correspondence: [email protected] † Authors equally contributed. Abstract: Itching is prevalent in children with skin disorders and associated with effects on their mood, quality of life, and social functioning. Surprisingly, there are no data on childhood prevalence of pruritus in the general population. The aim of this article is to explore the epidemiology, clinical manifestation, and treatment for itch (pruritus) in the pediatric population (from infancy to adoles- cence), and to be helpful to primary care physicians who assess and diagnose pediatric patients with itching. In this study, we searched for specific keywords using PubMed and MEDLINE (Ovid) and, then, refined the retrieved searches for each cause and treatment. As a result of reviewing the litera- ture, atopic dermatitis was shown to be the most common cause of itching, especially during infancy and through preschool. Not only skin disorders but also systemic diseases, drugs, and postburn states can predispose an individual to itching in childhood. There are traditional and newly developed treatment modalities for itching in pediatric patients. However, because the pharmacokinetics and Citation: Kang, S.-Y.; Um, J.-Y.; pharmacodynamics of childhood are different from those of adults, the medications for itching have Chung, B.-Y.; Kim, J.-C.; Park, C.-W.; to be applied carefully for these age groups.
    [Show full text]
  • Topographic Differential Diagnosis of Chronic Plaque Psoriasis
    Journal of Clinical Medicine Review Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks Paolo Gisondi * , Francesco Bellinato and Giampiero Girolomoni Section of Dermatology and Venereology, Department of Medicine, University of Verona, 37129 Verona, Italy; [email protected] (F.B.); [email protected] (G.G.) * Correspondence: [email protected] Received: 29 September 2020; Accepted: 5 November 2020; Published: 8 November 2020 Abstract: Background: Psoriasis is an inflammatory skin disease presenting with erythematous and desquamative plaques with sharply demarcated margins, usually localized on extensor surface areas. Objective: To describe the common differential diagnosis of plaque psoriasis classified according to its topography in the scalp, trunk, extremities, folds (i.e., inverse), genital, palmoplantar, nail, and erythrodermic psoriasis. Methods: A narrative review based on an electronic database was performed including reviews and original articles published until 1 September 2020, assessing the clinical presentations and differential diagnosis for psoriasis. Results: Several differential diagnoses could be considered with other inflammatory, infectious, and/or neoplastic disorders. Topographical differential diagnosis may include seborrheic dermatitis, tinea capitis, lichen planopilaris in the scalp; lupus erythematosus, dermatomyositis, cutaneous T-cell lymphomas, atopic dermatitis, syphilis, tinea corporis, pityriasis rubra pilaris in the trunk and arms; infectious intertrigo in the inguinal and intergluteal folds and eczema and palmoplantar keratoderma in the palms and soles. Conclusions: Diagnosis of psoriasis is usually straightforward but may at times be difficult and challenging. Skin cultures for dermatophytes and/or skin biopsy for histological examination could be required for diagnostic confirmation of plaque psoriasis. Keywords: psoriasis; plaque psoriasis; differential diagnosis; diagnosis; papulosquamous lesions 1.
    [Show full text]
  • WO 2015/037005 Al 19 March 2015 (19.03.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/037005 Al 19 March 2015 (19.03.2015) P O P C T (51) International Patent Classification: (74) Agents: AVERBUCH, Ariel et al; Dr.D.Graeser Ltd., 10 A61K 39/395 (2006.01) C07K 16/30 (2006.01) Zarhin St., Corex Building, 4366238 Raanana (IL). C07K 16/18 (2006.01) G01N 33/564 (2006.01) (81) Designated States (unless otherwise indicated, for every G01N 33/574 (2006.0 1) G01N 33/569 (2006.0 1) kind of national protection available): AE, AG, AL, AM, (21) International Application Number: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, PCT/IL20 14/0508 14 BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 11 September 2014 ( 11.09.2014) KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (25) Filing Language: English MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (26) Publication Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (30) Priority Data: TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 61/876,324 11 September 2013 ( 11.09.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: COMPUGEN LTD.
    [Show full text]
  • Infantile Psoriasis
    PEDIATRIC DERMATOLOGY Series Editor: Camila K. Janniger, MD Infantile Psoriasis Camila K. Janniger, MD; Robert A. Schwartz, MD, MPH; Maria Letizia Musumeci, MD, PhD; Aurora Tedeschi, MD; Barbara Mirona, MD; Giuseppe Micali, MD Psoriasis is a common inherited papulosqua- several chromosomes at which putative psoriasis mous dermatosis that may be a diagnostic genes may be located. Disease susceptibility genes dilemma, particularly in infants and children. The are thought to be present on chromosomes 4q, 6p, treatment of children with psoriasis should be 16q, and 20p. Moreover, on chromosome 1q, genes handled with caution and tailored according to regulating epidermal differentiation have been iden- the child’s age, as well as to the extent, distribu- tified. Linkage to this area has been proposed. tion, and type of psoriasis. Furthermore, psoriasis gene loci on chromosomes 2, Cutis. 2005;76:173-177. 8, and 20 have been suggested.12 Physical injury to the skin (Köbner phe- soriasis is a common inherited papulosquamous nomenon), low humidity,5 cold weather, and stress dermatosis that often represents a diagnostic may represent important triggering factors.9 Worsen- P dilemma in infants.1-3 The diagnosis may be ing of psoriasis following stress was observed in 50% challenging if the disease is mild or if the presenta- of 223 pediatric patients in one survey and in 90% tion is atypical.4 of 245 children in another.9,13 In addition, in young children, viral or bacterial infection (particularly Pathogenesis due to Streptococcus) may be a common initiating Both genetic and environmental factors interact to and maintaining factor, especially for the develop- precipitate the development of psoriasis.5 A family ment of acute guttate psoriasis.14,15 history of psoriasis is seen in 25% to 71% of patients In childhood, psoriasis may be induced by some with the disease.2,6-9 Generally, an earlier onset of medications, the most common being antimalarials the disease correlates with familial frequency7; the and systemic corticosteroids.
    [Show full text]
  • WO 2016/090347 Al 9 June 2016 (09.06.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/090347 Al 9 June 2016 (09.06.2016) P O P C T (51) International Patent Classification: (74) Agents: TESKIN, Robin L. et al; Leclair Ryan, P.C., In A61K 39/395 (2006.01) A61K 38/16 (2006.01) tellectual Property Department, 23 18 Mill Road, Suite C07K 16/46 (2006.01) 1100, Alexandria, Virginia 223 14 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/US20 15/064 146 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (22) International Filing Date: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 5 December 2015 (05.12.2015) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (26) Publication Language: English MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (30) Priority Data: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 62/088,058 5 December 2014 (05. 12.2014) US SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant: IMMUNEXT, INC. [US/US]; 16 Cavendish Court, Lebanon, New Hampshire 03766 (US).
    [Show full text]
  • ABC of Dermatology / [Edited By] Rachael Morris-Jones
    Dermatology Dermatology Sixth Edition EDITED BY Rachael Morris-Jones, FRCP, PhD, PCME Dermatology Consultant Kings College Hospital Denmark Hill London, UK This edition first published 2014 © 2014 by John Wiley & Sons, Ltd. © 1988, 1993, 1998, 1999, 2003, 2009 by Blackwell Publishing Ltd BMJ Books is an imprint of BMJ Publishing Group Limited, used under licence by John Wiley & Sons. Registered office: JohnWiley&Sons,Ltd,TheAtrium,SouthernGate,Chichester,WestSussex,PO198SQ,UK Editorial offices: 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 111 River Street, Hoboken, NJ 07030-5774, USA For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book.
    [Show full text]
  • Management of Pediatric Psoriasis Tina Bhutani, MD; Faranak Kamangar, Bsc; and Kelly M
    CM E Management of Pediatric Psoriasis Tina Bhutani, MD; Faranak Kamangar, BSc; and Kelly M. Cordoro, MD soriasis is a chronic inflamma- More than one-third of patients pres- children10 but, when present, are typi- tory disease of the skin, nails, ent before age 20.5-9 cally accompanied by systemic signs, Pand joints. Overall prevalence The pattern of psoriasis presenta- including fever, chills, malaise, and in the US is 2.5%.1-3 Among children tion in children can vary from what is subsequent dehydration and toxicity. aged 0 to 18 years, prevalence is 1% classically observed in adults. Children Nail involvement such as pitting, ony- and incidence is 40.8 per 100,000.4 have increased involvement of the face cholysis, and subungual debri can oc- and anogenital regions, and pruritus cur with all types of psoriasis and can CM E EDUCATIONAL OBJECTIVES is common.10 Plaque-type psoriasis is serve as a diagnostic clue (Figure 1e, 1. Provide a practical approach to the most common (73.7%)4 and presents as see page e2). management of psoriasis in the pediatric primary care setting. erythematous plaques with silvery-white The differential diagnosis for pso- scales typically involving the scalp, riasis in children depends on the site 2. Review the proper selection and utilization of topical agents for the postauricular region (Figure 1a, see page of involvement. Scalp psoriasis pres- management of pediatric psoriasis. e2), elbows, knees, umbilicus, and but- ents with discrete or confluent red 3. Recognize moderate-to-severe tocks (Figure 1b, see page e2). patches with silvery scale.
    [Show full text]
  • And Pediatric Dermatology Is Now an Integral Part of Most Dermatological and Pediatric Meetings
    Arnold P. Oranje Nawaf Al-Mutairi Tor Shwayder Editors Practical Pediatric Dermatology Controversies in Diagnosis and Treatment 123 Practical Pediatric Dermatology Arnold P. Oranje • Nawaf Al-Mutairi Tor Shwayder Editors Practical Pediatric Dermatology Controversies in Diagnosis and Treatment Editors Arnold P. Oranje Nawaf Al-Mutairi Kinderhuid.nl, Rotterdam Dermatology Unit Dermicis Huidziekenhuis Alkmaar Faculty of Medicine The Netherlands Kuwait University Kuwait Tor Shwayder Department of Dermatology Henry Ford Hospital Detroit , Michigan USA ISBN 978-3-319-32157-8 ISBN 978-3-319-32159-2 (eBook) DOI 10.1007/978-3-319-32159-2 Library of Congress Control Number: 2016946031 © Springer International Publishing Switzerland 2016 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made.
    [Show full text]
  • Psoriasis-Clinical Features
    BRITISH MEDICAL JOURNAL 24 jULY 1971 231 MEDICAL PRACTICE Br Med J: first published as 10.1136/bmj.3.5768.231 on 24 July 1971. Downloaded from Clinical Progress Psoriasis-Clinical Features HARVEY BAKER British Medical J'ournal, 1971, 3, 231-233 may also be involved.' Warin coined the term "napkin psoriasis" for such eruptions, which in the short term have an excellent Few dermatoses are as easily recognized and as morphologically prognosis and which respond well to topical corticosteroids. distinctive as classical psoriasis. Every clinical student quickly The relationship of this eruption to true psoriasis is disputed, learns to recognize the sharply defined salmon-red plaques, candidosis and seborrhoeic dermatitis having claims to its capped by silvery scales, occurring typically on the extensor lineage. Until long-term follow up studies have been undertaken aspects of the limbs. Much psoriasis is indeed classical but its nature will be debated, but its occurrence in psoriatic http://www.bmj.com/ few other than dermatologists appreciate the number of morpho- families and occasional reappearance as ordinary psoriasis logical variants with which this disease may present. Mis- later lend support to the contention that it occurs in infants diagnosis of "atypical" psoriasis is common and leads to with the psoriatic predisposition.' prognostic and therapeutic errors. The clinical features of psoriasis may be influenced by a variety of endogenous and environmental factors. This article will describe briefly the less GUTTATE PSORIASIS well recognized variants of psoriasis, some common and others uncommon yet in their This exanthem is typically seen in children aged 5 to 12 years, relatively minor, devastating on 1 October 2021 by guest.
    [Show full text]